![](/images/Email.png)
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
US Patent
Mitsubishi Tanabe Pharma Corporation
US Patent
Affinity DataIC50: 2.5nMpH: 8.0Assay Description:The PDE assay was performed according to a modified method referred to a report of Kotera et al. (Kotera et al., Biochem. Pharmacol., vol. 60, pp. 13...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)